Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;28(6):977-985.
doi: 10.1111/hae.14614. Epub 2022 Jun 29.

Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors

Anna Ter-Zakarian  1 , Richard F W Barnes  1 , Rebecca Kruse-Jarres  2 , Doris V Quon  3 , Shannon Jackson  4 , Haowei Linda Sun  5 , Annette von Drygalski  1
Affiliations

Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors

Anna Ter-Zakarian et al. Haemophilia. 2022 Nov.

Abstract

Introduction: Persons with haemophilia (PWH) have a higher prevalence of hypertension compared to the general population, which cannot be explained entirely by the usual cardiovascular risk factors. Neutralizing antibodies (inhibitors) against clotting factors might have some relation to cardiovascular disease in PWH. However, whether inhibitors facilitate hypertension is unknown.

Aim: We investigated the relationship between hypertension/blood pressure and inhibitors in PWH. Additional goals were to determine the relationships with haemophilia type, race, and viral status.

Methods: Records were extracted retrospectively for PWH (age ≥18 years) between 2003 and 2014 from four Hemophilia Treatment Centers in North America and included demographics, weight, height, haemophilia type/severity, HCV and HIV infection status, hypertension, use of anti-hypertensive medications, and inhibitor status. We fitted semiparametric generalized additive models (GAMs) to describe adjusted curves of blood pressure (BP) against age.

Results: Among 691 PWH, 534 had haemophilia A and 157 had haemophilia B, with a median age of 39 years (range 18 to 79). Forty-four PWH (6.5%) had a history of inhibitors, without evidence for a higher prevalence of hypertension or higher BP. A higher prevalence of hypertension and higher BP were noted for haemophilia A (vs. haemophilia B), coinfection with HCV/HIV (vs. uninfected), or moderate haemophilia (vs. severe haemophilia).

Conclusion: While there was no signal to suggest that a history of inhibitors is associated with hypertension, differences based on haemophilia type, severity, and viral infection status were identified, encouraging prospective investigations to better delineate haemophilia-specific risk factors for hypertension.

Keywords: blood pressure; haemophilia; hypertension; inhibitors.

PubMed Disclaimer

References

REFERENCES

    1. Hay CRM, Nissen F, Pipe SW. Mortality in congenital hemophilia A - a systematic literature review. J Thromb Haemost. 2021;19(S1):6-20. https://doi.org/10.1111/jth.15189
    1. Sood SL, Cheng D, Ragni M, et al. A cross-sectional analysis of cardiovascular disease in the hemophilia population. Blood Adv. 2018;2(11):1325-1333. https://doi.org/10.1182/bloodadvances.2018018226
    1. van de Putte DE, Fischer K, Makris M, et al. Increased prevalence of hypertension in haemophilia patients. Thromb Haemostasis. 2012;108(10):750-755. https://doi.org/10.1160/TH12-05-0313
    1. von Drygalski A, Kolaitis NA, Bettencourt R, et al. Prevalence and risk factors for hypertension in hemophilia. Hypertension. 2013;62(1):209-215. https://doi.org/10.1161/HYPERTENSIONAHA.113.01174
    1. SHARATHKUMAR AA, SOUCIE JM, TRAWINSKI B, GREIST A, SHAPIRO AD. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia. 2011;17(4):597-604. https://doi.org/10.1111/j.1365-2516.2010.02463.x

LinkOut - more resources